Abstrak
Nasopharyngeal carcinoma (NPC) is a genetic multifactor disease that has an endemic character.
1 NPC is a subset of squamous carcinoma cells at the head and neck. NPC is relatively rare in the world (80.000 new cases per year). Nevertheless, NPC shows considerable differences in geographic distribution.
2 Although many cases are found in countries with non-Mongoloid residents, South China still occupies the highest incidence with 2.500 new cases per year. NPC incidence in Mongoloid ethnics is a dominant factor; the frequency is quite high in South China, Hong Kong, Vietnam, Thailand, Malaysia, Singapore, and Indonesia. 3 Parkin et al. stated that the incidence of NPC by age average is generally less than 1/100.000 except the population in South China and in other Chinese regions, South-East Asia, South West India, Greece, Algeria and Tunisia, and in Alaska and Greenland. 4 Incidence of NPC is higher in men than in women with a ratio 2.3:1. In the population, the level of NPC risk is progressive along with rising of age. 4 In Indonesia, NPC can be found in many areas although case numbers vary among the regions. In Jakarta, the prevalence of the disease is more than 100 cases per year. Bandung shows an average of 60 cases, while Makassar 25 cases, Palembang 25 cases, Denpasar 15 cases, and West Sumatera 11 cases. Considering also the numbers of cases in Medan, Semarang, Surabaya and other cities, it indicates that NPC has spread across the Indonesian region. Dutt et al. 5 argued that the incidence of NPC is multifactorial and cannot be entirely explained. Current evidence supports existence of a relationship between environmental factors, food, genetics, and infection with Epstein -Barr virus (EBV).
5 Besides ethnic factors, increased incidence of NPC is reported to have links with environmental and socioeconomic factors, habits such as cigarette smoking and consumption of fermented and conserved food (e.g., salted and fumigated fi sh) and vegetable oils containing nitrosamines, as well as exposure to soot, dust with formaldehydes. Each of these factors can activate EBV and promote growth of NPC.
6,7 EBV infection is an important environmental factor in the aetiology of NPC tumorigenesis. EBV is not found in all normal cells of nasopharyngeal epithelium and the EBV genome is not present in all normal cells of nasopharyngeal epithelium, however, it can be found in all NPC cells. The cells of the immune system spontaneously recognize tumour cells and T-lymphocytes (T cells) become main effector cells in the immune surveillance of cancer. T cells recognize antigens presented by the major histocompatibility complex (MHC) through distribution of T cell receptor (TCR) clones, until distribution clones TCR can detect and see specifi c band T cell base uniqueness TCR.
8 Cytotoxic T cells are T-lymphocytes which mediate cytotoxic reactions to virus infected cells and stimulate macrophages to phagocyte these cells. 9 Hence, T cells, which eliminate virus-infected cells, play an important role in pathogenesis of NPC. Restriction fragment length polymorphisms (RFLP) of germ-line of TCR genes from Singaporean Chinese patients with NPC and healthy controls were analysed by Southernblot technique and hybridization with radioactively labeled TCR cDNA probes. The results suggested that TCR restriction may be important in the pathogenesis of NPC.
10 T cells generally shared arranged immune response through several T cell receptors. Thus, T cell receptors play a role in the immune system and several of abnormalities and diseases have been shown to occur along with T cell dysfunction.
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Possibilities to assess variant TCR at condition of T cell dysfunction can be detected by visible change at locus of TCR to assess abnormality of expression or TCR gene function.
12 Polymorphism of the TCR gene can infl uence T cell function, especially in occurrence and pathogenesis of diseases, for example hepatitis B. Polymorphism of TCR gene presenting allele and genotype TCR is estimated to be a predisposing factor of NPC. Polymorphism of TCR-β gene is related to individual susceptibilities to infection of hepatitis B virus (HBV) and it was reported that polymorphic sites of TCR-β gene exist at span of Cβ 1 -Cβ 2 .
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The genetic factor is a primary factor in the pathogenesis of NPC and epidemiology data states the importance of genetic factor as the cause of this disease. Nevertheless as a whole molecular genetic aspects from NPC such as polymorphisms of TCR-β gene have not yet been able to be evaluated. Conversely, nowadays no experiment has reported TCR-β gene polymorphisms in Indonesian population and its relation with susceptibilities to NPC.
The aims of the study are to investigate distribution of genotype TCR-β gene in Indonesian population and its relation with individual susceptibilities to NPC.
METHODS

Subject
The research was done from August 2006 till December 2008 and research subjects are patients who have been diagnosed of having NPC, whereas controls are healthy individuals. All research subjects were given informed consent before taking part in this research. Diagnosis of NPC was based on inspection of histopathology biopsies conducted by medical doctors in the Department ENT FMUI/RSCM Jakarta. Furthermore, NPC staging was specifi ed based on classifi cation of Union Internationale Contre Cancer (UICC). NPC patient primary in research classifi ed its tumour by Pathologist based on WHO criterion.
Study design
Design of this research is a descriptive explorative cross sectional study. The sample used in this research is 3 millilitre (ml) peripheral blood from NPC patients and healthy donors. According to Sastroasmoro and Ismael 14 using formula minimum samples with total amount of samples is 100 samples for NPC patients and healthy donors.
Genomic DNA Isolation
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Genomic DNA was isolated from blood. Peripheral blood (1,5 ml) was mixed with 4.5 ml Red Blood Cells solutions 1X (199 mM EDTA ; 100 mM KHCO 3 ; 1.45 NH 4 Cl), centrifuged at 1.500 rotations per minute (rpm) for 10 minutes at 27 o C to get a pellet. Supernatant was discarded and the pellet was lysed in RBC 1X and centrifuged like before to get a white pellet.
Then enhanced 1.3 ml cell lyses solutions (10 mM Tris HCl; 0.25 mM EDTA; 20% SDS) and the mixture was incubated at 37 o C for 30-60 minutes. Added to 1.3 ml precipitated protein (5M ammonium acetate) and vortexed till it turned milky. The mixture was centrifuged with 3.000 rpm at 4 o C for 15 minutes till it formed a brown pellet. Supernatants were transferred to new tubes containing 2.3 ml cool isopropanol and the tubes were inverted several times until precipitated DNA was visible. The DNA was then incubated overnight at -20 o C. Tubes containing isopropanol-incubated DNA were centrifuged at 3.000 rpm at 4 o C for 5 minutes. The DNA pellet is cleaned with 1.3 ml sterilized alcohol 70%, centrifuged at 3.000 rpm at 4 o C for 5 minute. DNA dry-aeration was run for 2 hours at RT. Furthermore, 300 ml TE (10 mM Tris HCl; 0.25 mM EDTA) was added to dissolve the DNA pellett and incubated at 37 o C for 2 hour. After that, DNA was transferred to eppendorf tubes of 1.5 ml and stored at -20 o C.
TCR-ß DNA amplifi cation and PCR-RFLP Technique
Amplifi cation of TCR-ß gene was performed by using forward primer 5' TACC TGGAGGCAGAGGAATG3' and reverse primer 5'CCCTCCCAAGCAGGTTATTT3'. Amplifi cation was done at the TCR-ß DNA that covers polymorphic sites Bgl II in 1.5 kb upstream direction of the end of 5' Cß 2 13 . Every 50 μl PCR mixture contain 20 μl template DNA, 10 pmol primer, 200 mM dNTPs (dTTP, dCTP, dGTP, dATP), 1.25 units Taq DNA polymerase, buffer solution contains 10 mM Tris-HCl pH 9, 50 mM KCl, 0.1% Triton X-100, 1.5 mM MgCl 2 and dd H 2 O. Amplifi cation consisted of denaturizing, annealing, and extension cycles at the PCR machine. PCR condition that was used for both primers is early denaturizing at 95 o C for 3 minutes, fi nal extension for 3 minutes, and 35 cycles with denaturizing in 94 o C for 30 seconds, annealing in 54 o C for 30 seconds, and extension in 72 o C for 40 seconds. For negative control, 20 μl dd H 2 O were added into PCR mixture. Furthermore, amplifi cation DNA (Amplicon) was checked by electrophoresis at 1% gel agarose. Into every well agarose enhanced mixture that contained of 10 μl amplicon and 3 μl loading buffers (0.25% bromophenol blue, xylene cyanol, 4% b/v sucrose) and then DNA separated with electrophoresis in 90 Volt for 60 minutes. For marking was used 100 bp DNA ladder. Bands of DNA fragments were visualized by an ultraviolet illuminator and documented by Polaroid camera.
After the positive result of TCR-ß DNA amplifi cation was proven with the existence of a DNA band of 229 bp, we furthermore conducted RFLP by using restriction enzyme Bgl II to detect polymorphism of the TCR-ß gene. The 15 μl TCR-ß amplicon enhanced to PCR tube, added dd H 2 O 3 μl, buffer O 2 μl, and Bgl II 1 μl. DNA mixture was incubated at 37 o C for 3 hours. After incubation, DNA mixture was checked by electrophoresis at 2% agarose. Into every well of the agarose gel was given enhanced mixture that consisted of 20 μl DNA and 3 μl loading buffer and then bands were separated electrophoretically like before. Results of PCR-RFLP as indicated by electrophoresis were DNA fragments that were visualized with an ultraviolet illuminator could be expressed positive if 1, 2, or 3 bands of TCR-β DNA were found at 229 bp, 142 bp, and 87 bp. Bands of DNA were documented with a Polaroid camera to analyse RFLP.
Statistical analyses
This research used nonparametric statistical analysis; to evaluate distribution and relations between two populations of genotype and allele of TCR-ß gene Chisquare test was used.
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RESULTS
DNA amplifi cation to detect polymorphic sites of TCR-β gene
Polymorphisms of TCR-β gene is shown by variation at span of TCR-β gene that cover polymorphic site Bgl II and located on 1.5 kb upstream direction the end of 5' Cβ 2 . Amplifi cation area is referred as span of Cβ 1 -Cβ 2 conducted with PCR, using a primer designed to produce a TCR-β PCR product of 229 bp. Therefore, successful amplifi cation of TCR-β DNA should result in a PCR product of 229 bp (Figure 1 .) This condition indicates that the primer has been precisely designed and is matching the expectations.
Analysis of the polymorphisms of TCR-β gene with RFLP method
Polymorphisms of TCR-β gene at span of Cβ 1 -Cβ 2 was determined by undertaking RFLP at 2% gel agarose. RFLP result from PCR-RFLP TCR-β DNA product are indicated through existence of cutting of DNA fragment by restriction enzyme Bgl II that producing 3 size of DNA bands like three genotype, where homozygote AA genotype is represented by single band DNA or wild type (229 pb), homozygote BB genotype is represented by double bands DNA (142 and 87 bp), and heterozygote AB genotype is represented by three bands DNA (229 bp, 142 bp, and 87 bp) (Figure 2) . At genotype homozygote AA restriction enzyme Bgl II could not recognize sequences of the restriction site that change from 5'-gatct-3' become 5'-aatct 3', so that band of DNA that formed have single band (229 bp).
At genotype homozygote BB restriction enzyme Bgl II could recognize sequence of restriction site at 5'-gatct-3', so that producing band of DNA that formed have double band (142 bp and 87 bp). Furthermore, the genotype heterozygote AB is combination by 2 patterns genotype homozygote AA and BB, so that will producing three DNA bands (229 bp, 142 bp, 87 bp).
Figure 1. PCR product of 229 bp of TCR-β gene after being run on 1% agarose gel for 60 minutes
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Distribution of TCR-β allele on NPC patients and control
At the Table 1 and Figure 3 we can see the genotype distribution and allele frequency of TCR-β gene on NPC group and control group. Tables 1 indicate that 
Distribution of TCR-β allele in China ethnic group and indigenous in Indonesia
DISCUSSION
Polymorphism of the TCR-β gene is shown by variation at span of TCR-β DNA that covers polymorphic restriction sites of Bgl II and located at 1.5 kilo base pairs, At AA homozygote genotype restriction enzyme Bgl II did not recognize restriction sites sequence that changed from 5'-gatct-3' to 5'-aatct 3', so that the DNA showed a single band (229 bp). At BB homozygote genotype restriction enzyme Bgl II recognized the restriction sites at 5'-gatct-3', so that produce two bands DNA (142 bp and 87 bp). Hereinafter, AB heterozygote genotype is combination from 2 patterns AA homozygote genotype and BB homozygote genotype, so that will produce three bands DNA (229 bp, 142 bp, 87 bp).
In consequence, at PCR-RFLP method changing of endonuclease restriction sites will produce different fragment length DNA.
17 Table 1 and Figure 3 indicate that distribution of genotype TCR-ß gene in NPC population and control shown that spreading pattern. By chi-square test, allele frequency of TCR-β gene between NPC group was not signifi cantly different with control group (p>0.05). But, distribution of A allele frequency TCR-β gene was tending to increase on NPC group. In this case, it can be anticipated that allotype TCR-β gene has infl uenced with susceptibilities of the individual to NPC, although the reality has been seen yet, where A allele frequency tend to increase at NPC patient and maybe predisposed at NPC pathogeneses. Involvement of A allele as predisposing factor of NPC will possibly be seen it reality if amount samples is improved two till three or conducted samples selection based staging of disease in tightens. Recognition EBV antigen by T cell through TCR also depend on antigen presentation by molecule HLA until HLA genotype class I and II on NPC patient also need to be considered, because HLA genotype modus certain to present EBV to T cell determine accuration and strong its cytotoxic response host to cell that infected by EBV.
18 Other epidemiologic evidence occurs in the number NPC in Singapore, where the biggest percentage of NPC is Chinese clan society (18.5 per 100.000 residents), followed up by Malay clan (6.5 per 100.000) and the last is Hindustani clan (0.5 per 100.000). 20 Furthermore, in Malaysia occurrence of NPC also many found in the Mongoloid race clan. 21 That number is signifi cantly higher compared to that in European countries or North America with prevalence 1 per 100.000 per year.
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According to research result by Devi et al. in SarawakMalaysia, cases of NPC also have high prevalence, which is 13.5 per 100.000 people. 23 Even though Korean, Japanese and north Chinese were included in Mongoloid race, not many were found to get NPC. Incidence of NPC in Asian countries is much higher compared to that in Europe or America. In UK, cases of NPC by age 0-14 year is 0.25 per 1.000.000 people, whereas by age 10-14 year is 0.8 per 1.000.000 people. Age estimating from England and Wales Cancer data indicates that 80% NPC patient at age 15-19 year, with number of occurrences 1-2 per 1.000.000 peoples.
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Analysis RFLP in germ-line gene TCR from 41 NPC patients and 54 normal patients at genomic DNA that transformed with EBV become B-lymphoblastoid cell line (BLCL) cutting with restriction enzyme BamHI, EcoRI, HindIII, and TaqI. In the combination of BamHI/ Vb11, NPC patients have lower frequency in fragment size of 25/25-kb and higher frequency at fragment 20-kb compared to control. Combination of TaqI/Vb8, fragment 4.3/3.2-kb has lower frequency at totalize NPC patient, especially in patients with HLA B46. This Result indicates that restriction TCR is anticipated to have an important role in response to EBV and NPC pathogenesis.
11 In a research performed by Hirankarn et al. 25 the association between HLA-E and genetic susceptibility to nasopharyngeal carcinogenesis was investigated by comparing the frequencies of HLA-E alleles in 100 Thai NPC patients and 100 healthy controls. HLA-E typing was performed by means of PCR-sequence-specifi c oligonucleotide probe method. The frequency of the HLA-E* 0103 allele and HLA-E 0103, 0103 genotype, but not others, was increased in NPC patients, compared to controls. This observation suggests a possible role for HLA-E in NPC development, possibly via natural killer cell or cytotoxic lymphocyte function.
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In conclusion, the distribution of TCR-β gene allele between NPC group and control groups showed no difference. The Distribution of TCR-β gene between ethnic Chinese and indigenous groups showed no difference. Polymorphisms TCR-β gene are not associated with NPC and ethnic groups present in the Indonesian population.
